A population based cohort study to monitor the safety and effectiveness of sirolimus in patients with sporadic lymphangioleiomyomatosis (S-LAM)

08/07/2019
23/04/2024
EU PAS number:
EUPAS30455
Study
Finalised
Documents
Study protocol
Initial protocol
English (423.23 KB - PDF) View document
Study results
Study results
English (1.75 MB - PDF) View document
English (4.05 MB - PDF) View document
Study report
Other information